Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
36 nmol/L for plasma and 938 nmol/L for red blood cells (22)
This could minimize the need for multiple medications and reduce the burden of constantly monitoring blood sugar levels
Given its high efficacy in reducing glycemia and weight, tirzepatide may also have potential anti-cancer properties
Tirzepatide boasts a proven safety history and confirmed outcomes, making it an excellent choice for individuals seeking a dependable method to reduce body mass, often resulting in a decrease of up to 22.5% in clinical studies
These efforts have led to the development of various GLP-1 receptor agonists, the most recent being semaglutide and tirzepatide, approved for the treatment of type 2 diabetes in 2018 and 2022, respectively
US$ 25.42
US$ 28.15
US$ 28.14
US$ 28.63
US$ 25.06
US$ 24.61
US$ 22.18
US$ 28.38
US$ 25.43
US$ 21.27
US$ 23.69
US$ 21.82
US$ 20.25
